Approximately 20% of those receiving dialysis in the U.S. are hesitant to be vaccinated against coronavirus disease 2019 (COVID-19), even if the vaccine was considered safe for the general population. This includes 29% of those aged 18 to 44 years, and 29% of Black responders. About 53% of those who were vaccine hesitant expressed concerns about side effects. Vaccine hesitancy was 50% higher among those aged 18 to 44 years, compared to those aged 45 to 64 years. Vaccine hesitancy was 90% higher in Black individuals, compared to non-Hispanic White individuals. Vaccine hesitancy was 100% higher in . . .